Fakultní nemocnice Brno, Interní hematologická a onkologická klinika

Brno 625 00

1 studies enrolling now · 2 studies all time

What they study most

Biliary Tract Cancer, Indolent Systemic Mastocytosis, Smoldering Systemic Mastocytosis

Studies at this site

• (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis — Recruiting now
• Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer — Recruiting now